我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

U50,488H对高脂大鼠血管内皮功能的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第5期
页码:
531-534
栏目:
基础研究
出版日期:
2015-05-05

文章信息/Info

Title:
Effect of U50,488H on vascular endothelial function in rats with hyperlipidemia
作者:
褚晓月郑煦阳田 菲李 嘉贾 敏李 娟裴建明
(第四军医大学基础医学部生理学教研室,陕西 西安 710032)
Author(s):
CHU Xiao-yue ZHENG Xu-yang TIAN Fei LI Jia JIA Min LI Juan PEI Jian-ming
(Department of Physiology, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
κ-阿片受体U50488H高脂血症血管内皮功能大鼠
Keywords:
kappa-opioid receptor U50488H hyperlipidemia vascular endothelial function rats
分类号:
R589.2
DOI:
-
文献标识码:
A
摘要:
目的 探讨κ-阿片受体(κ-OR)选择性激动剂U50,488H对高脂大鼠血管内皮功能的影响及其机制。方法 成年SD大鼠分别饲以正常和高脂饲料14周,腹腔隔日注射U50,488H和κ-OR阻断剂nor-BNI,麻醉后下腔静脉取血,检测总胆固醇(TC)及低密度脂蛋白(LDL)的水平。透射电子显微镜观察动脉内皮细胞和平滑肌细胞的超微结构改变。观察胸主动脉对内皮依赖性血管舒张剂乙酰胆碱(ACh)及内皮非依赖性血管舒张剂(SNAP)的舒张反应。结果 高脂饲料喂养可引起大鼠血清TC和LDL显著升高;主动脉血管内皮依赖性舒张功能显著降低。透射电镜下可见动脉内皮细胞和平滑肌细胞的超微结构出现损伤。U50,488H可显著减轻高脂血症引起的血管内皮依赖性舒张功能障碍和动脉内皮细胞与平滑肌细胞超微结构损伤,κ-OR阻断剂nor-BNI可以阻断U50,488H的上述作用。结论 高脂血症大鼠存在内皮功能障碍,U50,488H可通过激活κ-OR改善高脂血症导致的内皮结构改变和功能障碍。
Abstract:
AIM To study the effect of U50,488H, a selective agonist of kappa-opioid receptor, on vascular endothelial functions in rats with hyperlipidemia. METHODS Adult SD rats were fed with normal or high-fat diet for 14 weeks, respectively. U50,488H and normal saline (NS) were intraperitoneally injected on alternate days. Blood samples were harvested from inferior vena cava after anesthesia and total cholesterol and low-density lipoprotein were then detected. Ultrastructural changes of artery endothelial cells and smooth muscle cells were observed with transmission electron microscopy (TEM). The aorta was separated to observe the vasorelaxation reaction of thoracic aorta in response to acetylcholine (ACh), an endothelium-dependent vasodilating agent and SNAP, an endothelial-independent vasodilatation agent. RESULTS Endothelial structures were impaired under electron microscope in rats fed with a high-fat diet. There was a significant rise in blood lipid levels and a significantly lower thoracic aorta response to ACh. With treatment of U50,488H, endothelial structure and functions were significantly improved compared with those in high-fat diet group. The effects of U50,488H were blocked by nor-BNI, a selective kappa-opioid receptor antagonist. CONCLUSION Kappa-opioid receptor stimulation with U50,488H improves endothelial structure and functions in rats with hyperlipidemia.

参考文献/References

[1]李小玲,李 菁,朱伟杰,等.丝瓜络对高脂血症小鼠LDL-R基因表达的影响[J].中国病理生理杂志,2009,25(6):1156-1159.
[2]Chen C,Huang P,Liu-Chen LY.Identification and verification of proteins interacting with the kappa opioid receptor(KOPR)[J].Methods Mol Biol,2014,1230:129-140.
[3]Fukagawa H,Koyama T,Fukuda K.κ-Opioid receptor mediates the antinociceptive effect of nitrous oxide in mice[J].Br J Anaesth,2014,113(6):1032-1038.
[4]李 榕,姬秋和,马 恒,等.胰岛素对自发性高血压大鼠离体主动脉的舒张作用及机制[J].心脏杂志,2003,15(6):501-503.
[5]Goette A,Arndt M,Rocken C,et al.Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans[J].Circulation,2000,101(23):2678-2681.
[6]Novo G,Guttilla D,Fazio G,et al.The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS[J].Br J Clin Pharmacol,2008, 66(3):345-351.
[7]Tsai CT,Chiang FT,Chen WP,et al.Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger[J].Cell Calcium,2011,49(1):1-11.
[8]Urbano M,Guerrero M,Rosen H,et al.Antagonists of the kappa opioid receptor[J].Bioorg Med Chem Lett,2014,24(9):2021-2032.
[9]Hartung AM,Beutler JA,Navarro HA,et al.Stilbenes as kappa-selective, non-nitrogenous opioid receptor antagonists[J].J Nat Prod,2014,77(2):311-319.
[10]吴晓东,王 微,裴建明,等.κ-阿片受体激动剂U50,488H对血管紧张素II诱导内皮细胞产生白介素-6和白介素-8的影响[J].中国药理学通报2010, 26(7):922-925.
[11]Wang Q,Sun Y,Li J,et al.Quaternary ammonium salt of U50488H,a new kappa-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury[J].Eur J Pharmacol,2014,737:177-184.
[12]Heilig M,Schank JR.Kappa-opioid receptor antagonism: a mechanism for treatment of relief drinking?[J].Biol Psychiatry,2014,75(10):750-751.

备注/Memo

备注/Memo:
收稿日期:2014-12-07.
基金项目:国家自然科学基金项目资助(81270402)
通讯作者:李娟,讲师,主要从事阿片肽与心肺循环研究 Email:lijuan2162008@163.com
作者简介:褚晓月,硕士生 Email:xiaoyuechu@hotmail.com
更新日期/Last Update: 2015-04-28